federal_register: 2015-20235

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2015-20235 Rare Diseases: Common Issues in Drug Development; Draft Guidance for Industry; Availability Notice The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Rare Diseases: Common Issues in Drug Development." The purpose of this draft guidance is to advance and facilitate the development of drugs and biologics to treat rare diseases. Drug development for rare diseases has many challenges related to the nature of these diseases. This draft guidance is intended to assist sponsors of drug and biological products for treating rare diseases in conducting more efficient and successful development programs. 2015-08-17 2015 8 https://www.federalregister.gov/documents/2015/08/17/2015-20235/rare-diseases-common-issues-in-drug-development-draft-guidance-for-industry-availability https://www.govinfo.gov/content/pkg/FR-2015-08-17/pdf/2015-20235.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Rare Diseases: Common Issues in Drug Development." The purpose of this draft guidance is to advance and facilitate the...  

Links from other tables